BRANFORD, Conn., March 10, 2017 -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief Executive Officer, will present at the 29th Annual ROTH Conference on Tuesday, March 14, 2017, at 2:30 p.m. Pacific time (5:30 p.m. Eastern time). The conference is being held at The Ritz Carlton Laguna Niguel hotel in Dana Point, California.
Mr. Patton will be available for one-on-one meetings with the investment community on Tuesday, March 14. Please contact ROTH Capital Partners via the conference website if you would like to arrange a meeting.
Interested parties can access the audio webcast with slide presentation at www.casmed.com or directly at http://wsw.com/webcast/roth31/casm. An archived presentation will be available for 90 days.
About CASMED® – Monitoring What's Vital
CASMED products are designed to provide unique non-invasive monitoring solutions that are vital to patient care. The Company's FORE-SIGHT® Cerebral Oximeters provide a highly accurate, non-invasive measurement of tissue oxygenation in the brain. Direct monitoring of tissue oxygenation can provide a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygen in the brain and empower them to improve patient care. In addition to FORE-SIGHT oximeters and accessories, the Company also provides proprietary non-invasive blood pressure monitoring solutions for OEM use. For further information regarding CASMED, visit the Company's website at www.casmed.com.
| Company Contact CAS Medical Systems, Inc. Jeffery A. Baird Chief Financial Officer (203) 315-6303 [email protected] Investors LHA Bruce Voss / Jody Cain (310) 691-7100 [email protected] / [email protected] @LHA_IR_PR |


ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 



